Joost P Sluijter
Overview
Explore the profile of Joost P Sluijter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortega F, Roefs M, Perez D, Kooijmans S, de Jong O, Sluijter J, et al.
Nanomedicine
. 2019 Jun;
20:102014.
PMID: 31152797
Exosomes are cell-derived extracellular vesicles of 30-150 nm in size and are involved in intercellular communication. Because of their bioactive cargo, consisting of proteins, RNA and lipids, and their natural...
2.
Deddens J, Feyen D, Zwetsloot P, Brans M, Siddiqi S, van Laake L, et al.
PLoS One
. 2017 Mar;
12(3):e0173657.
PMID: 28319168
Background: Translational failure for cardiovascular disease is a substantial problem involving both high research costs and an ongoing lack of novel treatment modalities. Despite the progress already made, cell therapy...
3.
Koudstaal S, Jansen Of Lorkeers S, van Slochteren F, van der Spoel T, van de Hoef T, Sluijter J, et al.
J Cell Mol Med
. 2013 Aug;
17(9):1128-35.
PMID: 23910946
Pre-clinical studies aimed at treating ischemic heart disease (i.e. stem cell- and growth factor therapy) often consider restoration of the impaired microvascular circulation as an important treatment goal. However, serial...
4.
van Mil A, Vrijsen K, Goumans M, Metz C, Doevendans P, Sluijter J
J Mol Med (Berl)
. 2013 Apr;
91(8):1001-12.
PMID: 23625462
Instigated by the discovery of adult cardiac progenitor cells, cell replacement therapy has become a promising option for myocardial repair in the past decade. We have previously shown that human-derived...
5.
Arslan F, Smeets M, Buttari B, Profumo E, Rigano R, Akeroyd L, et al.
J Mol Cell Cardiol
. 2013 Jan;
56:116-28.
PMID: 23274064
Decreased haptoglobin (Hp) functionality due to allelic variations is associated with worsened outcome in patients after myocardial infarction (MI). However, mechanisms through which haptoglobin deficiency impairs cardiac repair remain to...
6.
Sluijter J, Doevendans P, Goumans M
Circulation
. 2011 Oct;
124(17):e456.
PMID: 22025645
No abstract available.
7.
van Mil A, Doevendans P, Sluijter J
Circ Cardiovasc Genet
. 2011 Feb;
4(1):e3.
PMID: 21325154
No abstract available.
8.
Te Boekhorst B, Bovens S, Hellings W, van der Kraak P, Van De Kolk K, Vink A, et al.
Cardiovasc Res
. 2010 Oct;
89(3):680-8.
PMID: 21030534
Aims: Neutrophil gelatinase-associated lipocalin (NGAL) is an effector molecule of the innate immune system. One of its actions is the prolongation of matrix metalloproteinase-9 (MMP-9) activity by the formation of...